852 related articles for article (PubMed ID: 11238922)
1. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
2. Coupling of DNA synthesis and histone synthesis in S phase independent of cyclin/cdk2 activity.
Nelson DM; Ye X; Hall C; Santos H; Ma T; Kao GD; Yen TJ; Harper JW; Adams PD
Mol Cell Biol; 2002 Nov; 22(21):7459-72. PubMed ID: 12370293
[TBL] [Abstract][Full Text] [Related]
3. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases.
Wohlschlegel JA; Dwyer BT; Takeda DY; Dutta A
Mol Cell Biol; 2001 Aug; 21(15):4868-74. PubMed ID: 11438644
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
Petersen BO; Lukas J; Sørensen CS; Bartek J; Helin K
EMBO J; 1999 Jan; 18(2):396-410. PubMed ID: 9889196
[TBL] [Abstract][Full Text] [Related]
6. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
[TBL] [Abstract][Full Text] [Related]
7. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of E2F-1 by cyclin A-cdk2.
Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
[TBL] [Abstract][Full Text] [Related]
9. The cyclin E/Cdk2 substrate and Cajal body component p220(NPAT) activates histone transcription through a novel LisH-like domain.
Wei Y; Jin J; Harper JW
Mol Cell Biol; 2003 May; 23(10):3669-80. PubMed ID: 12724424
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
Lents NH; Keenan SM; Bellone C; Baldassare JJ
J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
[TBL] [Abstract][Full Text] [Related]
11. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
[TBL] [Abstract][Full Text] [Related]
12. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
[TBL] [Abstract][Full Text] [Related]
14. Characterization of p21Cip1/Waf1 peptide domains required for cyclin E/Cdk2 and PCNA interaction.
Chen IT; Akamatsu M; Smith ML; Lung FD; Duba D; Roller PP; Fornace AJ; O'Connor PM
Oncogene; 1996 Feb; 12(3):595-607. PubMed ID: 8637717
[TBL] [Abstract][Full Text] [Related]
15. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
17. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
18. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
19. A low abundance pool of nascent p21WAF1/Cip1 is targeted by estrogen to activate cyclin E*Cdk2.
Prall OW; Carroll JS; Sutherland RL
J Biol Chem; 2001 Nov; 276(48):45433-42. PubMed ID: 11581254
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.
Manenti S; Yamauchi E; Sorokine O; Knibiehler M; Van Dorsselaer A; Taniguchi H; Ducommun B; Darbon JM
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):775-82. PubMed ID: 10359664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
